Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Audentes Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Audentes Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Audentes Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Audentes Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Audentes Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Audentes Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Audentes Therapeutics Raises USD65 Million in Series C Financing Round 12
Audentes Therapeutics Raises USD42.5 Million in Series B Financing 15
Cardiogen Sciences Secures USD0.52 Million in Venture Funding 17
Audentes Therapeutics Raises US$30 Million In Series A Financing 18
Audentes Therapeutics Raises Funds through Seed Financing 20
Partnerships 21
Audentes Therapeutics Amends Co-Development with University of Pennsylvania 21
Audentes Therapeutics Enters Into Co-Development Agreement With Genethon For AT001 22
Licensing Agreements 23
Audentes Therapeutics Enters Into Licensing Agreement With RegenxBio 23
Audentes Therapeutics Enters into Licensing Agreement with RegenxBio for CPVT 24
Audentes Therapeutics Amends its Licensing Agreement with University of Florida Research Foundation 26
Cardiogen Sciences Enters into Licensing Agreement with Fondazione Salvatore Maugeri 27
Audentes Therapeutics Enters Into Licensing Agreement with ReGenX Biosciences 28
Equity Offering 29
Audentes Therapeutics Prices Public Offering of Shares for USD150.8 Million 29
Audentes Therapeutics Raises USD231 Million in Public Offering of Shares 31
Audentes Therapeutics to Raise up to USD75 Million in Public Offering of Shares 33
Audentes Therapeutics Raises USD86.3 Million in Public Offering of Shares 34
Audentes Therapeutics Raises USD75 Million in IPO 36
Acquisition 37
Audentes Therapeutics Acquires Cardiogen Sciences 37
Audentes Therapeutics Inc – Key Competitors 38
Audentes Therapeutics Inc – Key Employees 39
Audentes Therapeutics Inc – Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Recent Developments 41
Financial Announcements 41
Aug 07, 2018: Audentes Therapeutics Reports Second Quarter 2018 Financial Results 41
May 09, 2018: Audentes Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update 43
Mar 08, 2018: Audentes Therapeutics Announces Fourth Quarter 2017 And Full Year Financial Results 45
Nov 14, 2017: Audentes Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update 46
Aug 10, 2017: Audentes Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update 47
May 11, 2017: Audentes Therapeutics Reports First Quarter 2017 Financial Results and Provides Corporate Update 49
Mar 09, 2017: Audentes Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update 51
Jan 09, 2017: Audentes Therapeutics Provides Full Year 2017 Strategic Outlook and Financial Guidance 54
Corporate Communications 56
Oct 03, 2018: Audentes Therapeutics announces co-founder and chief executive Officer Matthew R. Patterson appointed chairman of the alliance for regenerative medicine 56
May 08, 2018: Audentes Therapeutics Announces the Promotion of Natalie Holles to President and Chief Operating Officer 57
Dec 13, 2017: Audentes Therapeutics Appoints Mark A. Goldberg, M.D. to its Board of Directors 58
Jun 13, 2017: Audentes Therapeutics Appoints Jennifer Jarrett to Board of Directors 59
May 08, 2017: Audentes Therapeutics Announces Appointment of John T. Gray, Ph.D. to Senior Vice President and Chief Scientific Officer 60
Product News 61
04/30/2018: Audentes Therapeutics Announces Presentation of Data at the 21st Annual Meeting of the American Society of Gene and Cell Therapy 61
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62
Audentes Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Audentes Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Audentes Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Audentes Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Audentes Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Audentes Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Audentes Therapeutics Raises USD65 Million in Series C Financing Round 12
Audentes Therapeutics Raises USD42.5 Million in Series B Financing 15
Cardiogen Sciences Secures USD0.52 Million in Venture Funding 17
Audentes Therapeutics Raises US$30 Million In Series A Financing 18
Audentes Therapeutics Raises Funds through Seed Financing 20
Audentes Therapeutics Amends Co-Development with University of Pennsylvania 21
Audentes Therapeutics Enters Into Co-Development Agreement With Genethon For AT001 22
Audentes Therapeutics Enters Into Licensing Agreement With RegenxBio 23
Audentes Therapeutics Enters into Licensing Agreement with RegenxBio for CPVT 24
Audentes Therapeutics Amends its Licensing Agreement with University of Florida Research Foundation 26
Cardiogen Sciences Enters into Licensing Agreement with Fondazione Salvatore Maugeri 27
Audentes Therapeutics Enters Into Licensing Agreement with ReGenX Biosciences 28
Audentes Therapeutics Prices Public Offering of Shares for USD150.8 Million 29
Audentes Therapeutics Raises USD231 Million in Public Offering of Shares 31
Audentes Therapeutics to Raise up to USD75 Million in Public Offering of Shares 33
Audentes Therapeutics Raises USD86.3 Million in Public Offering of Shares 34
Audentes Therapeutics Raises USD75 Million in IPO 36
Audentes Therapeutics Acquires Cardiogen Sciences 37
Audentes Therapeutics Inc, Key Competitors 38
Audentes Therapeutics Inc, Key Employees 39
Audentes Therapeutics Inc, Subsidiaries 40
List of Figures
Audentes Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Audentes Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Audentes Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Audentes Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Audentes Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Audentes Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Audentes Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Audentes Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9